Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia-Reference-Cited by-同舟云学术

Loss of α-hemoglobin–stabilizing protein impairs erythropoiesis and exacerbates β-thalassemia

Published:2004-11-15 Issue:10 Volume:114 Page:1457-1466
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Kong Yi,Zhou Suiping,Kihm Anthony J.,Katein Anne M.,Yu Xiang,Gell David A.,Mackay Joel P.,Adachi Kazuhiko,Foster-Brown Linda,Louden Calvert S.,Gow Andrew J.,Weiss Mitchell J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Thalassemia: The consequences of unbalanced hemoglobin synthesis

2. Hemoglobin synthesis in β-thalassemia: the properties of the free α-chains

3. Excess α Chain Synthesis Relative to β Chain Synthesis in Thalassaemia Major and Minor

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anemia and iron overload as prognostic markers of outcomes in β-thalassemia;Expert Review of Hematology;2024-07-26

2. Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin);Journal of Clinical Medicine;2024-04-24

3. Impact of α-Globin Gene Expression and α-Globin Modifiers on the Phenotype of β-Thalassemia and Other Hemoglobinopathies: Implications for Patient Management;International Journal of Molecular Sciences;2024-03-17

4. The modulation effect of green tea and pumpkin oils on hyperlipidemia, oxidative stress, and hematological abnormalities in an experimental multiple sclerosis rat model;Clinical Phytoscience;2024-03-04

5. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches;Cell Communication and Signaling;2024-02-15